Trials / Not Yet Recruiting
Not Yet RecruitingNCT06817655
The Research of French PaRole OncO : A Peer Supported Program for Cancer Patients
Implementation and Evaluation of Peer Support in Oncology in France : a Multisite Participatory Action Research - Adaptation and Transfer in France of the Quebec PAROLE ONCO Research Program
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 720 (estimated)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach. The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on: 1. Evaluating clinical and psychosocial parameters 2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.
Detailed description
Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach. The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on: 1. Evaluating clinical and psychosocial parameters 2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | PaRole OncO France : Individual peer support | Following the development of the peer support program "PaRole OncO France", we are now proceeding with its implementation and evaluation through a pilot study. This study aims to derive both implementation-related and clinically relevant results. Prior to their assignment, all peer helpers undergo a comprehensive training course to ensure they are well-equipped for their role. Patients receive individual peer support during their treatment visits, providing real-time assistance and support within the clinical setting. The study incorporates three key measurement time points: 1. Baseline measurement (before the intervention) 2. After the intervention 3. Follow-up measurement (1months after the first intervention) 4. Follow-up measurement (6 months after the first intervention) At each time points, participants will complete a set of standardized questionnaires. These instruments are designed to capture relevant outcomes and experiences related to the peer support intervention. |
Timeline
- Start date
- 2025-03-15
- Primary completion
- 2027-06-15
- Completion
- 2027-06-15
- First posted
- 2025-02-10
- Last updated
- 2025-02-10
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06817655. Inclusion in this directory is not an endorsement.